131 related articles for article (PubMed ID: 35588152)
21. Human Papillomavirus and Factors Associated with Recurrence in Sinonasal Inverted Papillomas from Poland and Spain.
Fulla M; Szafarowski T; Frias-Gomez J; Quiros B; Clavero O; Gomà M; Pavon MA; Jurek-Matusiak O; Lares HR; Mañós M; Alemany L; Mena M; Gonzalez X
Head Neck Pathol; 2020 Sep; 14(3):758-767. PubMed ID: 31916205
[TBL] [Abstract][Full Text] [Related]
22. [Expression of fascin and correlation with MVD in sinonasal inverted papilloma].
Cai Y; Zhang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jul; 26(14):629-32. PubMed ID: 23156804
[TBL] [Abstract][Full Text] [Related]
23. HPV-Positive Status Is an Independent Factor Associated With Sinonasal Inverted Papilloma Recurrence.
Viitasalo S; Ilmarinen T; Lilja M; Hytönen M; Hammarén-Malmi S; Auvinen E; Hagström J; Dillner J; Aaltonen LM
Laryngoscope; 2022 Sep; 132(9):1714-1718. PubMed ID: 34694020
[TBL] [Abstract][Full Text] [Related]
24. Association of Krouse Classification for Sinonasal Inverted Papilloma With Recurrence: A Systematic Review and Meta-analysis.
Lisan Q; Moya-Plana A; Bonfils P
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1104-1110. PubMed ID: 28973390
[TBL] [Abstract][Full Text] [Related]
25. [Analysis on the prognosis of malignant transformation of sinonasal inverted papilloma].
Lu X; Yu H; Liu G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 29(16):1451-4. PubMed ID: 26665454
[TBL] [Abstract][Full Text] [Related]
26. Blood transfusion requirements for endoscopic sinonasal inverted papilloma resections.
Habib AR; Hathorn I; Sunkaraneni VS; Srubiski A; Javer AR
J Otolaryngol Head Neck Surg; 2012 Dec; 41(6):413-8. PubMed ID: 23700587
[TBL] [Abstract][Full Text] [Related]
27. Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review.
Re M; Gioacchini FM; Bajraktari A; Tomasetti M; Kaleci S; Rubini C; Bertini A; Magliulo G; Pasquini E
Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):2991-3000. PubMed ID: 28432463
[TBL] [Abstract][Full Text] [Related]
28. [Prediction of the original location of sinonasal inverted papilloma by preoperative imaging].
Fang G; Wang C; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(23):1902-6. PubMed ID: 25980173
[TBL] [Abstract][Full Text] [Related]
29. Unique volatile metabolite signature of sinonasal inverted papilloma detectable in plasma and nasal secretions.
Chaskes MB; Lee YE; Toskala E; Nyquist G; Rosen M; Kimball B; Rabinowitz M
Int Forum Allergy Rhinol; 2022 Oct; 12(10):1254-1262. PubMed ID: 35143106
[TBL] [Abstract][Full Text] [Related]
30. Expression of Sp100 Protein in Human Papillomavirus-Associated Sinonasal Inverted Papilloma.
Wang F; Zhang J; Wang H; Li W
Ear Nose Throat J; 2021 Jan; 100(1):NP21-NP25. PubMed ID: 31272209
[TBL] [Abstract][Full Text] [Related]
31. Analysis of miRNA expression profiling identifies miR-214-3p as a novel biomarker in sinonasal inverted papilloma.
Teng Y; Li Y; Lin Z; Gao Y; Cao X; Lou X; Lin F; Li Y
Epigenomics; 2018 Dec; 10(12):1541-1553. PubMed ID: 29952653
[TBL] [Abstract][Full Text] [Related]
32. The analysis of expression of p16 protein in group of 53 patients treated for sinonasal inverted papilloma.
Zydroń R; Marszałek A; Bodnar M; Kosikowski P; Greczka G; Wierzbicka M
Braz J Otorhinolaryngol; 2018; 84(3):338-343. PubMed ID: 28479047
[TBL] [Abstract][Full Text] [Related]
33. Association Between Human Papilloma Virus Infection and Malignant Sinonasal Inverted Papilloma.
Ding R; Sun Q; Wang Y
Laryngoscope; 2021 Jun; 131(6):1200-1205. PubMed ID: 33111993
[TBL] [Abstract][Full Text] [Related]
34. [Risk factors of malignant transformation of sinonasal inverted papilloma].
Wang M; Hou L; Zhou B; Li Y; Cui S; Huang Q; Sun Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 35(7):627-632. PubMed ID: 34304493
[No Abstract] [Full Text] [Related]
35. Loss of p16 expression is a risk factor for recurrence in sinonasal inverted papilloma.
Menendez M; Cabal VN; Vivanco B; Suarez-Fernandez L; Lopez F; Llorente JL; Hermsen MA; Alvarez-Marcos C
Rhinology; 2022 Dec; 60(6):453-461. PubMed ID: 36173184
[TBL] [Abstract][Full Text] [Related]
36. NGS-based miRNome identifies miR-449 cluster as marker of malignant transformation of sinonasal inverted papilloma.
Re M; Tomasetti M; Monaco F; Amati M; Rubini C; Foschini MP; Sollini G; Gioacchini FM; Pasquini E; Santarelli L
Oral Oncol; 2021 Nov; 122():105554. PubMed ID: 34653751
[TBL] [Abstract][Full Text] [Related]
37. Sinonasal inverted papilloma recurrence rates and evaluation of current staging systems.
Mak W; Webb D; Al-Salihi S; Dadgostar A; Javer A
Rhinology; 2018 Dec; 56(4):407-414. PubMed ID: 30033450
[TBL] [Abstract][Full Text] [Related]
38. Sinonasal inverted papilloma: From diagnosis to treatment.
Lisan Q; Laccourreye O; Bonfils P
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Nov; 133(5):337-341. PubMed ID: 27053431
[TBL] [Abstract][Full Text] [Related]
39. The clinical behavior of sinonasal inverted papilloma with cellular dysplasia: case series and review of the literature.
Safadi A; Yafit D; Abu-Ghanem S; Ungar OJ; Wengier A; Abergel A; Fliss DM; Koren I
Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3375-3382. PubMed ID: 28597339
[TBL] [Abstract][Full Text] [Related]
40. Desmoglein 3 is overexpressed in inverted papilloma and squamous cell carcinoma of sinonasal cavity.
Huang CC; Lee TJ; Chang PH; Lee YS; Chuang CC; Jhang YJ; Chen YW; Chen CW; Tsai CN
Laryngoscope; 2010 Jan; 120(1):26-9. PubMed ID: 19688857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
